Sitemap
May 13, 2009 Articles
Filter by Available Specialty
- Alcon achieves more than 95% stake in WaveLight
- Bromocriptine mesylate approved for treatment of type 2 diabetes
- Diet, exercise interventions reduced functional decline in older, overweight cancer survivors
- Improvements in contact lens technology expand options, safety
- Intolerance to hypoxia might be a significant risk factor for RVO, study shows
- Neuronavigation allows surgeons to safely reach posterior orbital tumors
- New report projects that Medicare trust fund will be exhausted by 2017
- New treatment options for keratoconus
- NSABP C-08 initial safety report: FOLFOX6 plus bevacizumab did not increase toxicities
- Ovarian conservation at time of hysterectomy and long-term outcomes
- Practicality of rabies postexposure prophylaxis guidelines questioned
- Single-molecule agent lowered BP in stage I and II hypertension
- Single-molecule agent lowered BP in stage I and II hypertension
- Spectral domain OCT provides a more complete picture of macular telangiectasia
- Statin use may reduce risk for prostate cancer
- Topical administration of new oligonucleotide effectively treats corneal neovascularization in small study